Viking Therapeutics (VKTX) Interest & Investment Income (2016 - 2025)
Historic Interest & Investment Income for Viking Therapeutics (VKTX) over the last 12 years, with Q4 2025 value amounting to $7.0 million.
- Viking Therapeutics' Interest & Investment Income fell 3512.54% to $7.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $33.7 million, marking a year-over-year decrease of 1767.46%. This contributed to the annual value of $33.7 million for FY2025, which is 1767.46% down from last year.
- Latest data reveals that Viking Therapeutics reported Interest & Investment Income of $7.0 million as of Q4 2025, which was down 3512.54% from $7.8 million recorded in Q3 2025.
- In the past 5 years, Viking Therapeutics' Interest & Investment Income ranged from a high of $11.8 million in Q2 2024 and a low of $125000.0 during Q3 2021
- Over the past 5 years, Viking Therapeutics' median Interest & Investment Income value was $4.6 million (recorded in 2023), while the average stood at $4.6 million.
- Per our database at Business Quant, Viking Therapeutics' Interest & Investment Income plummeted by 8259.62% in 2021 and then skyrocketed by 169723.32% in 2023.
- Over the past 5 years, Viking Therapeutics' Interest & Investment Income (Quarter) stood at $159000.0 in 2021, then soared by 360.38% to $732000.0 in 2022, then soared by 542.9% to $4.7 million in 2023, then skyrocketed by 130.43% to $10.8 million in 2024, then tumbled by 35.13% to $7.0 million in 2025.
- Its Interest & Investment Income stands at $7.0 million for Q4 2025, versus $7.8 million for Q3 2025 and $9.0 million for Q2 2025.